Eliav Barr

Eliav Barr serves as the Head of Global Clinical Development and Chief Medical Officer at Merck Research Laboratories since January 2016, overseeing all late-stage development in vaccines and infectious diseases. Prior roles at Merck include Senior Vice President of Global Medical and Scientific Affairs and Senior Vice President for Vaccines and Infectious Diseases Global Clinical Development. Eliav Barr has also held positions as Vice President for Infectious Diseases and Oncology at Merck Research Laboratories and served as Executive Director at Merck Sharp & Dohme. Educational credentials include a Doctor of Medicine (MD) degree from Thomas Jefferson University, completed between 1982 and 1986.